FDA News
🇺🇸 FDA Page 18FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 205–216 of 391 articles
FDA's Permanent Ban on Compounded GLP-1s: What It Means for Pharma
FDA · GLP-1 · 3 min
Dr. Sarah MitchellFDA Eases Restrictions on Peptides: Implications for Drug Approvals
FDA · 2 min
Dr. Sarah MitchellFDA Guidance on Next-Gen Sequencing for Gene Therapy Safety
FDA · gene therapy · 2 min
Dr. Sarah MitchellFDA's Restructuring Opportunity Amid China Competition
FDA · 2 min
Dr. Sarah Mitchell5 FDA Drug Approvals to Watch in 2026
FDA · 2 min
Dr. Sarah MitchellaltRx GLP-1 Review 2026: FDA Updates on Semaglutide
FDA · GLP-1 · 2 min
Dr. Sarah MitchellPennsylvania Compounding Pharmacy Receives FDA Warning Letter
FDA · 2 min
Dr. Sarah MitchellWockhardt Secures US FDA Approval for ZAYNICH: A Milestone for Indian Pharma
FDA · 2 min
Dr. Sarah MitchellReplimune's Third FDA Approval Attempt and Pfizer's China Deal
FDA · 3 min
Dr. Sarah MitchellFriday Five: Key Regulatory Updates in Pharma
FDA · hepatitis · 3 min
Dr. Sarah MitchellZydus Lifesciences Secures FDA Priority Review for Liver Disease Drug
FDA · liver disease · 3 min
Dr. Sarah MitchellFDA Device Guidance Agenda: Key Regulatory Updates for 2026
FDA · 3 min
Dr. Sarah MitchellExplore intelligence